- Home
- FBRX vs CFBK Comparison
FBRX vs CFBK Comparison
Compare FBRX & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRX
- CFBK
- Stock Information
- Founded
- FBRX N/A
- CFBK 1892
- Country
- FBRX United States
- CFBK United States
- Employees
- FBRX N/A
- CFBK N/A
- Industry
- FBRX Biotechnology: Pharmaceutical Preparations
- CFBK Major Banks
- Sector
- FBRX Health Care
- CFBK Finance
- Exchange
- FBRX Nasdaq
- CFBK Nasdaq
- Market Cap
- FBRX 154.5M
- CFBK 151.6M
- IPO Year
- FBRX N/A
- CFBK 1998
- Fundamental
- Price
- FBRX $12.94
- CFBK $23.20
- Analyst Decision
- FBRX Strong Buy
- CFBK Buy
- Analyst Count
- FBRX 3
- CFBK 1
- Target Price
- FBRX $68.00
- CFBK $29.00
- AVG Volume (30 Days)
- FBRX 94.9K
- CFBK 21.1K
- Earning Date
- FBRX 11-13-2025
- CFBK 10-31-2025
- Dividend Yield
- FBRX N/A
- CFBK 1.38%
- EPS Growth
- FBRX N/A
- CFBK 36.66
- EPS
- FBRX N/A
- CFBK 2.77
- Revenue
- FBRX N/A
- CFBK $52,793,000.00
- Revenue This Year
- FBRX N/A
- CFBK $39.98
- Revenue Next Year
- FBRX N/A
- CFBK $10.47
- P/E Ratio
- FBRX N/A
- CFBK $8.38
- Revenue Growth
- FBRX N/A
- CFBK 20.91
- 52 Week Low
- FBRX $4.11
- CFBK $19.23
- 52 Week High
- FBRX $28.68
- CFBK $31.17
- Technical
- Relative Strength Index (RSI)
- FBRX 49.05
- CFBK 40.75
- Support Level
- FBRX $11.00
- CFBK $23.20
- Resistance Level
- FBRX $15.01
- CFBK $23.97
- Average True Range (ATR)
- FBRX 1.15
- CFBK 0.47
- MACD
- FBRX 0.01
- CFBK 0.02
- Stochastic Oscillator
- FBRX 48.82
- CFBK 46.63
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).
About CFBK CF Bankshares Inc.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.